These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9499605

  • 1. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis.
    Sharquie KE, Najim RA, Farjou IB.
    Clin Exp Dermatol; 1997 Jul; 22(4):169-73. PubMed ID: 9499605
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
    Ranawaka RR, Weerakoon HS.
    J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
    [Abstract] [Full Text] [Related]

  • 3. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M, Anwar AE.
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [Abstract] [Full Text] [Related]

  • 4. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis.
    Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ.
    Dermatology; 2004 Mar; 209(1):46-9. PubMed ID: 15237267
    [Abstract] [Full Text] [Related]

  • 5. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J, Valda-Rodriquez L, Toledo J, Vera-Navarro L, Luz M, Monasterios-Torrico H, Vega J, Berman J.
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
    Ranawaka RR, Weerakoon HS, de Silva SH.
    Int J Dermatol; 2015 Nov; 54(5):555-63. PubMed ID: 25600472
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
    Bumb RA, Mehta RD, Ghiya BC, Jakhar R, Prasad N, Soni P, Lezama-Davila C, Satoskar AR.
    Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
    [Abstract] [Full Text] [Related]

  • 8. Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites.
    Najim RA, Sharquie KE, Al-Zubaidy SA.
    Ann Trop Med Parasitol; 2006 Jan; 100(1):33-8. PubMed ID: 16417711
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M, Baum S, Barzilai A, Pavlotsky F, Trau H, Schwartz E.
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G, Miller RS, Oster C, Jackson J, Aronson N.
    Clin Infect Dis; 2002 Aug 01; 35(3):261-7. PubMed ID: 12115091
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate.
    Tallab TM, Bahamdam KA, Mirdad S, Johargi H, Mourad MM, Ibrahim K, el Sherbini AH, Karkashan E, Khare AK, Jamal A.
    Int J Dermatol; 1996 Aug 01; 35(8):594-7. PubMed ID: 8854166
    [Abstract] [Full Text] [Related]

  • 13. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
    Llanos-Cuentas A, Tulliano G, Araujo-Castillo R, Miranda-Verastegui C, Santamaria-Castrellon G, Ramirez L, Lazo M, De Doncker S, Boelaert M, Robays J, Dujardin JC, Arevalo J, Chappuis F.
    Clin Infect Dis; 2008 Jan 15; 46(2):223-31. PubMed ID: 18171254
    [Abstract] [Full Text] [Related]

  • 14. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M, Baum S, Barzilai A, Scope A, Trau H, Schwartz E.
    J Am Acad Dermatol; 2007 Apr 15; 56(4):612-6. PubMed ID: 17276541
    [Abstract] [Full Text] [Related]

  • 15. Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India.
    Bumb RA, Prasad N, Khandelwal K, Aara N, Mehta RD, Ghiya BC, Salotra P, Wei L, Peters S, Satoskar AR.
    Br J Dermatol; 2013 May 15; 168(5):1114-9. PubMed ID: 23298394
    [Abstract] [Full Text] [Related]

  • 16. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
    Sundar S, Kumar K, Chakravarty J, Agrawal D, Agrawal S, Chhabra A, Singh V.
    Trans R Soc Trop Med Hyg; 2006 Jul 15; 100(7):698-700. PubMed ID: 16325873
    [Abstract] [Full Text] [Related]

  • 17. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA, Jaffary F, Ansari N, Siadat AH, Nilforoushan Z, Firouz A.
    J Vector Borne Dis; 2008 Dec 15; 45(4):287-91. PubMed ID: 19248655
    [Abstract] [Full Text] [Related]

  • 18. A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution.
    Sharquie KE.
    J Dermatol; 1995 Oct 15; 22(10):732-7. PubMed ID: 8586751
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.
    Almeida R, D'Oliveira A, Machado P, Bacellar O, Ko AI, de Jesus AR, Mobashery N, Brito Santos J, Carvalho EM.
    J Infect Dis; 1999 Nov 15; 180(5):1735-7. PubMed ID: 10515844
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini Harandi A.
    Ann Trop Med Parasitol; 2003 Jul 15; 97(5):493-8. PubMed ID: 12930612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.